ANG Lifesciences India Ltd

ANG Lifesciences India Ltd (ANG) is a micro-cap Healthcare company valued at ₹49 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

ANG Lifesciences India Ltd last traded at ₹37.75, modestly down 0.08% on the day.

Recent developments

On 2026-06-30, the company reported a net loss of ₹11 crore for the fiscal year ending March 2026, reflecting a narrowing loss compared to the previous year. Promoter shares pledged reached 44.88% of promoter holding as of June 2026.

Financial performance

The company's annual revenue remained flat at ₹93 crore, but its annual net loss narrowed from ₹12 crore to ₹11 crore. The latest quarter saw revenue drop 37.8% year-over-year to ₹15 crore, while the net loss widened to ₹4 crore from ₹2 crore in the same quarter a year earlier.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.88 times book value.

Things to watch

The company continues to report a net loss, with return on equity at 0.0% and return on capital employed at -3.9%. Revenue has declined at a 25.0% annualized rate over the past three years and 9.6% over five years. The latest quarter's net loss widened, and the stock is 24.0% below its 52-week high.

Where it stands

The company remains in a net loss position, with the latest quarter's net loss widening to ₹4 crore. Promoter shares pledged now account for 44.88% of their holding, and the stock is 24.0% below its 52-week high. The most significant movement is the widening net loss in the latest quarter.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.